Nova Patents
PL3254703T3

Adeno-associated virus virions with variant capsid and methods of use thereof

Abstract

This record has no abstract on file.

Term

5.6 yearsto projected expiry

Projected expiry 20 April 2032, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

128 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
201161478355United States of AmericaP
12774323European Patent Office (EPO)A
2012034413United States of AmericaW

Members128

Family members, oldest first
DocumentOfficeKind
CA2833870A1CanadaA1
CA3069946A1CanadaA1
WO2012145601A2World Intellectual Property Organization (WIPO)A2
WO2012145601A3World Intellectual Property Organization (WIPO)A3
AU2012245328A1AustraliaA1
SG194583A1SingaporeA1
IL228976A0IsraelA0
IL228976D0IsraelD0
CN103561774AChinaA
EP2699270A2European Patent Office (EPO)A2
KR20140024395ARepublic of KoreaA
JP2014518614AJapanA
US2014294771A1United States of AmericaA1
MX2013012384AMexicoA
EP2699270A4European Patent Office (EPO)A4
US2014364338A1United States of AmericaA1
ZA201307968BSouth AfricaB
RU2013151885ARussian FederationA
US2015225702A1United States of AmericaA1
US2015232953A1United States of AmericaA1
US9193956B2United States of AmericaB2
US2016184394A1United States of AmericaA1
CN105755044AChinaA
ZA201409129BSouth AfricaB
AU2012245328B2AustraliaB2
US9458517B2United States of AmericaB2
CN103561774BChinaB
US2016375151A1United States of AmericaA1
US2016376323A1United States of AmericaA1
AU2016273850A1AustraliaA1
JP6072772B2JapanB2
RU2611202C2Russian FederationC2
US9587282B2United States of AmericaB2
EP2699270B1European Patent Office (EPO)B1
JP2017113002AJapanA
MX349138BMexicoB
BR112013027120A2BrazilA2
CN107012171AChinaA
PT2699270TPortugalT
DK2699270T3DenmarkT3
LT2699270TLithuaniaT
ES2638342T3SpainT3
SMT201700443T1San MarinoT1
HRP20171334T1CroatiaT1
RS56246B1SerbiaB1
SI2699270T1SloveniaT1
EP3254703A1European Patent Office (EPO)A1
PL2699270T3PolandT3
US9856539B2United States of AmericaB2
HUE034510T2HungaryT2
SG10201800873WASingaporeA
CY1119765T1CyprusT1
HK1247855AHong Kong, ChinaA
HK1247855A1Hong Kong, ChinaA1
AU2018236725A1AustraliaA1
AU2016273850B2AustraliaB2
US10202657B2United States of AmericaB2
US10214785B2United States of AmericaB2
US2019218627A1United States of AmericaA1
KR20200016988ARepublic of KoreaA
EP3254703B1European Patent Office (EPO)B1
JP2020028308AJapanA
CA2833870CCanadaC
DK3254703T3DenmarkT3
PT3254703TPortugalT
LT3254703TLithuaniaT
KR102121355B1Republic of KoreaB1
RS60207B1SerbiaB1
AU2018236725B2AustraliaB2
HRP20200762T1CroatiaT1
SI3254703T1SloveniaT1
EP3693025A1European Patent Office (EPO)A1
SMT202000386T1San MarinoT1
HUE049629T2HungaryT2
PL3254703T3This recordPolandT3
AU2020244399A1AustraliaA1
ES2791499T3SpainT3
KR102202908B1Republic of KoreaB1
KR20210006514ARepublic of KoreaA
RU2742724C1Russian FederationC1
IL228976AIsraelA
IL228976BIsraelB
IL280819AIsraelA
IL280819D0IsraelD0
RU2742724C9Russian FederationC9
CN107012171BChinaB
JP2021121638AJapanA
EP3693025B1European Patent Office (EPO)B1
CY1122902T1CyprusT1
SG10202110919YASingaporeA
DK3693025T3DenmarkT3
PT3693025TPortugalT
FI3693025T3FinlandT3
BR112013027120B1BrazilB1
US11236402B2United States of AmericaB2
LT3693025TLithuaniaT
RS62795B1SerbiaB1
PL3693025T3PolandT3
SMT202200036T1San MarinoT1
HRP20220036T1CroatiaT1
Showing 100 of 128